Evidence map›Paper›PMID 24854422›Full record

ArticlePLoS pathogens2014

TNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection.

Frank M Szaba, Lawrence W Kummer, Debra K Duso, Ekaterina P Koroleva, Alexei V Tumanov, Andrea M Cooper, James B Bliska, Stephen T Smiley, Jr-Shiuan Lin

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Infection and immunity · 2019
    Article
  12. Article
  13. CCR2Infection and immunity · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2016
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Frank M SzabaTrudeau Institute, Saranac Lake, New York, United States of America.
Lawrence W KummerTrudeau Institute, Saranac Lake, New York, United States of America.
Debra K DusoTrudeau Institute, Saranac Lake, New York, United States of America.
Ekaterina P KorolevaTrudeau Institute, Saranac Lake, New York, United States of America.
Alexei V TumanovTrudeau Institute, Saranac Lake, New York, United States of America.
Andrea M CooperTrudeau Institute, Saranac Lake, New York, United States of America.
James B BliskaCenter for Infectious Diseases and Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, New York, United States of America.
Stephen T SmileyTrudeau Institute, Saranac Lake, New York, United States of America.
Jr-Shiuan LinTrudeau Institute, Saranac Lake, New York, United States of America.
Trudeau Institute · USStony Brook University · US

Funding

Viral Pathogenesis and TherapeuticsU54AI057158 · NIAID · WADSWORTH CENTER · PI LEVY, DAVID E · 2003 to 2014
$100.8M
Cell-mediated protection against pneumonic plagueR01AI061577 · NIAID · TRUDEAU INSTITUTE, INC. · PI LIN, JR-SHIUAN · 2004 to 2013
$3.8M
Roles for coagulation in immunityR01AI071295 · NIAID · TRUDEAU INSTITUTE, INC. · PI SMILEY, STEPHEN T · 2008 to 2011
$1.8M
NIAID NIH HHS R01 AI061577NIAID NIH HHS R01-AI061577NIAID NIH HHS R01 AI071295NIAID NIH HHS R01-AI071295NIAID NIH HHS U54 AI057158NIAID NIH HHS U54-AI057158
6 · The paper itself

Abstract

Septic pneumonias resulting from bacterial infections of the lung are a leading cause of human death worldwide. Little is known about the capacity of CD8 T cell-mediated immunity to combat these infections and the types of effector functions that may be most effective. Pneumonic plague is an acutely lethal septic pneumonia caused by the Gram-negative bacterium Yersinia pestis. We recently identified a dominant and protective Y. pestis antigen, YopE69-77, recognized by CD8 T cells in C57BL/6 mice. Here, we use gene-deficient mice, Ab-mediated depletion, cell transfers, and bone marrow chimeric mice to investigate the effector functions of YopE69-77-specific CD8 T cells and their relative contributions during pulmonary Y. pestis infection. We demonstrate that YopE69-77-specific CD8 T cells exhibit perforin-dependent cytotoxicity in vivo; however, perforin is dispensable for YopE69-77-mediated protection. In contrast, YopE69-77-mediated protection is severely impaired when production of TNFα and IFNγ by CD8 T cells is simultaneously ablated. Interestingly, TNFα is absolutely required at the time of challenge infection and can be provided by either T cells or non-T cells, whereas IFNγ provided by T cells prior to challenge appears to facilitate the differentiation of optimally protective CD8 T cells. We conclude that cytokine production, not cytotoxicity, is essential for CD8 T cell-mediated control of pulmonary Y. pestis infection and we suggest that assays detecting Ag-specific TNFα production in addition to antibody titers may be useful correlates of vaccine efficacy against plague and other acutely lethal septic bacterial pneumonias.

Indexed as

AnimalsCD8-Positive T-LymphocytesCells, CulturedImmunity, CellularInterferon-gammaMiceMice, Inbred C57BLMice, KnockoutPlaguePneumonia, BacterialPore Forming Cytotoxic ProteinsTumor Necrosis Factor-alphaYersinia pestisInterferon-gammaperforin, mousePore Forming Cytotoxic ProteinsTumor Necrosis Factor-alpha

Identifiers

PMID24854422
PMCPMC4031182
OpenAlexW2067910103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.